110 related articles for article (PubMed ID: 7766737)
1. Review article: omeprazole and the cytochrome P450 system.
Petersen KU
Aliment Pharmacol Ther; 1995 Feb; 9(1):1-9. PubMed ID: 7766737
[TBL] [Abstract][Full Text] [Related]
2. [Omeprazole and the cytochrome P450 system of the liver].
Petersen KU
Leber Magen Darm; 1993 Sep; 23(5):186-92. PubMed ID: 8412467
[TBL] [Abstract][Full Text] [Related]
3. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
Curi-Pedrosa R; Daujat M; Pichard L; Ourlin JC; Clair P; Gervot L; Lesca P; Domergue J; Joyeux H; Fourtanier G
J Pharmacol Exp Ther; 1994 Apr; 269(1):384-92. PubMed ID: 8169844
[TBL] [Abstract][Full Text] [Related]
4. Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450.
Diaz D; Fabre I; Daujat M; Saint Aubert B; Bories P; Michel H; Maurel P
Gastroenterology; 1990 Sep; 99(3):737-47. PubMed ID: 2136526
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies specific and inhibitory to human cytochromes P450 2C8, 2C9, and 2C19.
Krausz KW; Goldfarb I; Buters JT; Yang TJ; Gonzalez FJ; Gelboin HV
Drug Metab Dispos; 2001 Nov; 29(11):1410-23. PubMed ID: 11602516
[TBL] [Abstract][Full Text] [Related]
6. Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man.
Venkatakrishnan K; von Moltke LL; Duan SX; Fleishaker JC; Shader RI; Greenblatt DJ
J Pharm Pharmacol; 1998 Mar; 50(3):265-74. PubMed ID: 9600717
[TBL] [Abstract][Full Text] [Related]
7. Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes.
Runge D; Köhler C; Kostrubsky VE; Jäger D; Lehmann T; Runge DM; May U; Stolz DB; Strom SC; Fleig WE; Michalopoulos GK
Biochem Biophys Res Commun; 2000 Jun; 273(1):333-41. PubMed ID: 10873607
[TBL] [Abstract][Full Text] [Related]
8. Diazepam metabolism by cDNA-expressed human 2C P450s: identification of P4502C18 and P4502C19 as low K(M) diazepam N-demethylases.
Jung F; Richardson TH; Raucy JL; Johnson EF
Drug Metab Dispos; 1997 Feb; 25(2):133-9. PubMed ID: 9029042
[TBL] [Abstract][Full Text] [Related]
9. Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin.
Rost KL; Brösicke H; Brockmöller J; Scheffler M; Helge H; Roots I
Clin Pharmacol Ther; 1992 Aug; 52(2):170-80. PubMed ID: 1505152
[TBL] [Abstract][Full Text] [Related]
10. The anti-carcinogenic plant compound indole-3-carbinol differentially modulates P450-mediated steroid hydroxylase activities in mice.
Baldwin WS; LeBlanc GA
Chem Biol Interact; 1992 Aug; 83(2):155-69. PubMed ID: 1505058
[TBL] [Abstract][Full Text] [Related]
11. Regulation of constitutive rat hepatic cytochromes P450 by 3-methylcholanthrene.
Jones EJ; Riddick DS
Xenobiotica; 1996 Oct; 26(10):995-1012. PubMed ID: 8905915
[TBL] [Abstract][Full Text] [Related]
12. Omeprazole and lansoprazole are not inducers of cytochrome P4501A2 under conventional therapeutic conditions.
Rizzo N; Padoin C; Palombo S; Scherrmann JM; Girre C
Eur J Clin Pharmacol; 1996; 49(6):491-5. PubMed ID: 8706775
[TBL] [Abstract][Full Text] [Related]
13. Inhibition and induction of cytochrome P450 2B1 in rat liver by promazine and chlorpromazine.
Murray M
Biochem Pharmacol; 1992 Sep; 44(6):1219-22. PubMed ID: 1417944
[TBL] [Abstract][Full Text] [Related]
14. Induction of cytochrome P4501A by smoking or omeprazole in comparison with UDP-glucuronosyltransferase in biopsies of human duodenal mucosa.
Buchthal J; Grund KE; Buchmann A; Schrenk D; Beaune P; Bock KW
Eur J Clin Pharmacol; 1995; 47(5):431-5. PubMed ID: 7720765
[TBL] [Abstract][Full Text] [Related]
15. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
[TBL] [Abstract][Full Text] [Related]
16. The duration of induction and species influences the downregulation of cytochrome P450 by the interferon inducer polyinosinic acid-polycytidylic acid.
Anari MR; Cribb AE; Renton KW
Drug Metab Dispos; 1995 May; 23(5):536-41. PubMed ID: 7587927
[TBL] [Abstract][Full Text] [Related]
17. Role of the aromatic hydrocarbon receptor in the suppression of cytochrome P-450 2C11 by polycyclic aromatic hydrocarbons.
Safa B; Lee C; Riddick DS
Toxicol Lett; 1997 Feb; 90(2-3):163-75. PubMed ID: 9067484
[TBL] [Abstract][Full Text] [Related]
18. Induction of the male-specific cytochrome P450 3A2 in female rats by phenytoin.
Ghosal A; Sadrieh N; Reik L; Levin W; Thomas PE
Arch Biochem Biophys; 1996 Aug; 332(1):153-62. PubMed ID: 8806720
[TBL] [Abstract][Full Text] [Related]
19. Affinities for the aryl hydrocarbon receptor, potencies as aryl hydrocarbon hydroxylase inducers and relative toxicities of polychlorinated biphenyls. A congener specific approach.
Kafafi SA; Afeefy HY; Ali AH; Said HK; Abd-Elazem IS; Kafafi AG
Carcinogenesis; 1993 Oct; 14(10):2063-71. PubMed ID: 8222055
[TBL] [Abstract][Full Text] [Related]
20. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
Li XQ; Andersson TB; Ahlström M; Weidolf L
Drug Metab Dispos; 2004 Aug; 32(8):821-7. PubMed ID: 15258107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
